# US 2019/0314443 A1 · Composition for suppressing muscular atrophy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314443 A1
- Document ID: US20190314443A1
- Status: Published application
- Kind: A1
- Application number: 16/466,488
- Filed: 2017-12-04
- Published: 2019-10-17
- Earliest claimed: 2016-12-05
- Assignees: Otsuka Pharmaceutical Co., Ltd.
- Applicants: Otsuka Pharmaceutical Co., Ltd.
- Inventors: Muneshige SHIMIZU; Akina SHIOKAWA; Koichiro HAMADA; Kiyohiko MAGATA; Takeshi NIKAWA; Ayako MAITA
- Web page: https://patentgrep.com/patent/US20190314443A1

## CPC

- A61K 38/05: Dipeptides
- A23L 33/18: Peptides; Protein hydrolysates
- A61K 38/06: Tripeptides
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 21/04: for myasthenia gravis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a composition for suppressing muscular atrophy, comprising as an active ingredient(s) one or more peptides selected from the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK; the group consisting of dipeptides comprising F; and the group consisting of dipeptides DI, IY, YN, and NP.

## Claims

### Claim 1

A method for suppressing muscular atrophy, comprising administering to a subject one or more peptides selected from
the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK;
the group consisting of dipeptides comprising F; and
the group consisting of dipeptides DI, IY, YN, and NP.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the one or more peptides are selected from the group consisting of dipeptides comprising F.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the one or more peptides are selected from
the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK; and
the group consisting of dipeptides DI, DF, IF, FN, FY, IY, YN, and NP.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the one or more peptides comprise FN.

### Claim 5 (depends on 1)

The method according to claim 1, for preventing or treating a disease with muscular atrophy.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the disease is sarcopenia, disuse muscle atrophy, muscular dystrophy, diabetic amyotrophy, cachexia, steroid myopathy, drug induced myopathy, rhabdomyolysis, myasthenia gravis, amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, or stress urinary incontinence.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the one or more peptides are comprised in a pharmaceutical product.

### Claim 8

A method for improving low muscle mass, comprising administering to a subject one or more peptides selected from
the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK;
the group consisting of dipeptides comprising F; and
the group consisting of dipeptides DI, IY, YN, and NP.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the one or more peptides are selected from the group consisting of dipeptides comprising F.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the one or more peptides are selected from
the group consisting of tripeptides DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK; and
the group consisting of dipeptides DI, DF, IF, FN, FY, IY, YN, and NP.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the one or more peptides comprise FN.

### Claim 12 (depends on 8)

The method according to claim 8, for improving stress urinary incontinence.

### Claim 13 (depends on 8)

The method according to claim 8, for improving urine leakage.

### Claim 14 (depends on 8)

The method according to claim 8, wherein the one or more peptides are comprised in a food or drink.
